Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11921774 | 0.90 | GAA (0.43) | GAAALDH1A1LMNACYP1A2CYP3A4 | |
| SCHEMBL11921787 | 0.88 | LMNA (0.36) | GAAALDH1A1LMNACYP1A2CYP3A4 | |
| SCHEMBL11921789 | 0.82 | NPC1 (0.41) | ALDH1A1LMNACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL15259406 | 0.79 | GAA (0.36) | GAAALDH1A1TYRCYP3A4HPGD | |
| SCHEMBL11921776 | 0.78 | NPC1 (0.40) | GAAALDH1A1LMNACYP1A2CYP3A4 | |
| SCHEMBL11921788 | 0.76 | LNPEP (0.35) | LMNACYP1A2CYP3A4MAOALNPEP | |
| SCHEMBL11925960 | 0.76 | GAA (0.39) | GAAALDH1A1 | |
| SCHEMBL11921764 | 0.76 | TYR (0.36) | GAAALDH1A1TYRHPGDTDP1 | |
| SCHEMBL16270508 | 0.74 | CYP1A2 (0.56) | GAAALDH1A1LMNACYP1A2CYP3A4 | |
| SCHEMBL16270242 | 0.73 | LMNA (0.57) | GAAALDH1A1LMNACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2018-07-12 | — | — | US | disclosed |
| US-9868696-B2 | Amino acid derivatives and absorbable polymers therefrom | Bezwada Biomedial, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | disclosed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | disclosed |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-06-25 | — | — | US | disclosed |
| US-9012677-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-9012677-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-8901341-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8901341-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8461372-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC | 2013-06-11 | — | — | US | disclosed |
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | SLC7A1, SLC3A2, BCAT2 | GAA 2297/4885ALDH1A1 2903/4885TYR 1891/4885 |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | GAA 2510/4885ALDH1A1 3569/4885TYR 1897/4885 |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | GAA 2510/4885ALDH1A1 3569/4885TYR 1897/4885 |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | GAA 2510/4885ALDH1A1 3569/4885TYR 1897/4885 |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | GAA 2510/4885ALDH1A1 3569/4885TYR 1897/4885 |
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | GAA 2510/4885ALDH1A1 3569/4885TYR 1897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.